Prevalence and Associated Factors of Diabetic Retinopathy in People with Type 2 Diabetes Attending Community Based Diabetic Retinopathy Screening in Greater Bandung, Indonesia
Article Sidebar
Main Article Content
http://orcid.org/0000-0003-3062-8133
Syumarti Syumarti
Mayang Rini
Nina Ratnaningsih
Erwin Iskandar
Iwan Sovani
Rova Virgana
Muhammad Rinaldi Dahlan
Abstract
Introduction: Determine the prevalence and associated factors of diabetic retinopathy (DR) among people with type 2 diabetes.
Design: Cross-sectional study
Methods: We obtained data of people with type 2 diabetes retrospectively from a community-based DR screening database in Greater Bandung, Indonesia. We encoded the two fields mydriatic 45-degree fundus images to estimate prevalence. The associated factors analysis used multivariate logistic regression.
Results: We screened a total of 4,251 people with type 2 diabetes from January 2016 to December 2019. The overall age-standardised prevalence of any DR was 30.7% (95% CI: 28.7%-32.8%) and vision-threatening DR 7.6% (95% CI: 6.5%-9.0%). The following factors were associated with a higher prevalence of any DR: ages 50+ (OR:1.37; 95% CI:1.05-1.77), duration of diabetes five to ten years (OR:1.38; 95% CI:1.11-1.71) and more than ten years (OR:1.40; 95% CI:1.13-1.73), and postprandial blood glucose 200 mg/dl and higher (OR:1.27; 95% CI:1.03-1.52). The following factors were associated with a higher prevalence of vision-threatening DR: duration of diabetes five to ten years (OR:2.01; 95% CI:1.39-2.91) and more than ten years (OR:1.86; 95% CI:1.28-2.71), postprandial blood glucose 200 mg/dl or higher (OR:1.52; 95% CI:1.05-2.21) and systolic blood pressure 180 mmHg or higher (OR:2.67; 95% CI:1.16-6.17).
Conclusion: Diabetic retinopathy is prevalent among people with type 2 diabetes. People with diabetes should regulate their blood glucose and blood pressure to prevent retinopathy related vision loss.
Keywords
prevalence, diabetic retinopathy, vision-threatening, associated factors, Indonesia
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
2. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.
3. Hu FB. Globalisation of Diabetes. The role of diet, lifestyle, and genes. 2011;34(6):1249-1257.
4. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care. 2012;35(3):556-564.
5. Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260-277.
6. Sasongko MB, Widyaputri F, Agni AN, et al. Prevalence of Diabetic Retinopathy and Blindness in Indonesian Adults With Type 2 Diabetes. Am J Ophthalmol. 2017;181:79-87.
7. Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280.
8. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
9. Rachmawati S, Prihhastuti-Puspitasari H, Zairina E. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review. Journal of basic and clinical physiology and pharmacology. 2019;30(6):/j/jbcpp.2019.2030.issue-2016/jbcpp-2019-0350/jbcpp-2019-0350.xml.
10. Khoe LC, Wangge G, Soewondo P, Tahapary DL, Widyahening IS. The implementation of community-based diabetes and hypertension management care program in Indonesia. PloS one. 2020;15(1):e0227806-e0227806.
11. Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med. 2003;20(12):965-971.
12. Salamanca O, Geary A, Suárez N, Benavent S, Gonzalez M. Implementation of a diabetic retinopathy referral network, Peru. Bull World Health Organ. 2018;96(10):674-681.
13. Papavasileiou E, Dereklis D, Oikonomidis P, Grixti A, Kumar B, Prasad S. An effective programme to systematic diabetic retinopathy screening in order to reduce diabetic retinopathy blindness. Hell J Nucl Med. 2014;17 Suppl 1:30-34.
14. Vujosevic S, Benetti E, Massignan F, et al. screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol. 2009;148(1):111-118.
15. Piyasena M, Murthy GVS, Yip JLY, et al. Systematic review and meta-analysis of diagnostic accuracy of detection of any level of diabetic retinopathy using digital retinal imaging. Syst Rev. 2018;7(1):182.
16. Scanlon PH. Update on Screening for Sight-Threatening Diabetic Retinopathy. Ophthalmic Research. 2019;62(4):218-224.
17. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428-431.
18. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64-68.
19. Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Medicine (Baltimore). 2020;99(9):e19236.
20. Leasher JL, Bourne RRA, Flaxman SR, et al. Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010. Diabetes Care. 2016;39(9):1643-1649.
21. Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of Diabetic Retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-656.
22. Lin S, Ramulu P, Lamoureux EL, Sabanayagam C. Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review. Clin Exp Ophthalmol. 2016;44(4):300-320.
23. Vujosevic S, Aldington SJ, Silva P, et al. screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020.
24. Solomon SD, Chew E, Duh EJ, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412-418.
25. Liu L, Yue S, Wu J, et al. Prevalence and risk factors of retinopathy in patients with or without metabolic syndrome: a population-based study in Shenyang. BMJ open. 2015;5(12):e008855.
26. Roy Chowdhury S, Thomas RL, Dunseath GJ, et al. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of beta-Cell Function. J Clin Endocrinol Metab. 2016;101(2):572-580.
27. Shiraiwa T, Kaneto H, Miyatsuka T, et al. Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients. Diabetes Care. 2005;28(11):2806-2807.
28. Takao T, Takahashi K, Yoshida Y, et al. Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data. Journal of Diabetes Investigation.n/a(n/a).
29. Klein R, Klein BEK. Blood pressure control and diabetic retinopathy. Br J Ophthalmol. 2002;86(4):365-367.
30. Nkondi Mbadi AN, Longo-Mbenza B, Mvitu Muaka M, Mbungu FS, Lemogoum D. Relationship between pulse pressure, visual impairement and severity of diabetic retinopathy in sub-Saharan Africa. Mali Med. 2009;24(3):17-21.
31. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869-1875.
32. Yamamoto M, Fujihara K, Ishizawa M, et al. Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus. J Am Heart Assoc. 2019;8(8):e010627.